Journals / Dicle Tıp Dergisi / 2020 / Cilt: 47 - Sayı: 3

Parkinson's Disease Profile – A 17-Year Patient Analysis

Pages
508–516
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Taking these results into consideration, we had the opportunity to correct our shortcomings in our future studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:causes disability in advanced stages.
📊
Key Findings & Data:Factors that increase the risk in Parkinson's disease are male gender, old age, white race, environmental conditions, trauma, vascular diseases, family history, and genetic mutations.
💡
Conclusion & Impact:Taking these results into consideration, we had the opportunity to correct our shortcomings in our future studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

causes disability in advanced stages. The main pathology is the degeneration of the basal ganglia, especially the substantia nigra. In the clinic, motor and non-motor findings (NMF) are seen, and treatment approach is symptomatic. Factors that increase the risk in Parkinson's disease are male gender, old age, white race, environmental conditions, trauma, vascular diseases, family history, and genetic mutations. In this study, idiopathic Parkinson's patients who came to our movement disorders outpatient clinic in the last 17 years were evaluated retrospectively. We aimed to determine the IPD profile in our region through demographic and clinical findings and treatments used and compare the results with the literature. Methods: We evaluated 1150 patients admitted to the neurology department of movement disorders outpatient clinic due to parkinsonism. Five hundred seventy-eight patients with IPD were included in the study. Demographic data such as age, sex, place of birth, place of residence (rural/urban), comorbidities, family history, and habits were recorded. Results: A total of 63.5% of the patients were male. The mean age of the patients was 68.51(SD ± 10.35) years old for males and 68.37(SD ± 11.22) years old for females, 62.61(SD ± 11.31) for males and 62.55(SD ± 12.46) for females. 66.4% of the patients had the first clinical finding as tremor, while 55.4% had the tremor as the leading complaint. It was seen that 57% of the patients had NMF. It was observed that 52.8% of the patients did not have dementia. As the clinical stage progressed, it was determined that there was a significant increase in dementia rate. Hypertension (HT) (M/F%:35,2/47,2 p=0.01) and thyroid diseases (M/F%:2.3/10.3 p=0,00) were more frequent in female patients than in male patients. Impulsive-compulsive behaviors (ICBs) which are treatment-related problems were more common in males than in females (M/F%:17.8/8.5 p=0,00). Conclusion: The results were found to be similar to the literature. In this study, we have noticed the neglected, incomplete, or inadequately questioned parameters in routine-intensive outpatient conditions. Taking these results into consideration, we had the opportunity to correct our shortcomings in our future studies.

🔖

Cite This Article

ADIGUZEL, A., OZTURK, U., ALTINAYAR, S. (2020). Parkinson's Disease Profile – A 17-Year Patient Analysis. Dicle Tıp Dergisi, Cilt: 47 - Sayı: 3, 508–516. https://ajindex.com/articles/150360

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bekris LM, Mata IF, Zabetian CP. The Genetics ofParkinson Disease, Journal of Geriatric Psychiatry andNeurology. 2010
  2. 228–42. 2.Arikanoglu A, Hunkar R, Cınar K. Parkinsonismsecondary to bilateral subdural hematoma. Dicle Med J.2011
  3. Kalia LV, Lang AE. Parkinson disease in 2015: Evolvingbasic, pathological and clinical concepts in PD. Nat RevNeurol. 2016
  4. 65–6. 4.Gaare JJ, Skeie GO, Tzoulis C, Larsen JP, Tysnes OB.Familial aggregation of Parkinson's disease may affectprogression of motor symptoms and dementia.Movement disorders: official Journal of the MovementDisorder Society. 2017
  5. Breckenridge CB, Berry C, Chang ET, Sielken Jr RL,Mandel JS. Association between Parkinson’s Disease andCigarette Smoking, Rural Living, Well-WaterConsumption, Farming and Pesticide Use: SystematicReview and Meta-Analysis. PloS one. 2016
  6. e0151841. 6.Ritz B, Lee PC, Lassen CF, Arah OA. Parkinson diseaseand smoking revisited: ease of quitting is an early sign ofthe disease. Neurology. 2014
  7. 1396–402. 7.PD MED Collaborative Group. Long-term eff ectivenessof dopamine agonists and monoamine oxidase Binhibitors compared with levodopa as initial treatmentfor Parkinson’s disease (PD MED): a large, open-label,pragmatic randomised trial. Lancet. 2014
  8. 1196–205. 8.Martin I, Dawson VL, Dawson TM. Recent advances inthe genetics of Parkinson's disease. Annu Rev GenomicsHum Genet. 2011
  9. 301–25. 9.Driver JA, Logroscino G, Gaziano JM, Kurth T. Incidenceand remaining lifetime risk of Parkinson disease inadvanced age. Neurology. 2009
  10. 432–8. 10.Pringsheim T, Jette N, Frolkis A, Steeves TDL. Theprevalence of Parkinson’s disease: a systematic reviewand meta-analysis. Mov Disord. 2014
  11. 1583–90. 11.Benito-León J1, Bermejo-Pareja F, Rodríguez J, et al.Prevalence of PD and other types of parkinsonism inthree elderly populations of central Spain NeurologicalDisorders in Central Spain (NEDICES) Study Group. Movdisord. 2003
  12. Picillo M, Nicoletti A, Fetoni V, et al. The relevance ofgender in Parkinson's disease: a review. J Neurol. 2017Aug
  13. 264(8): 1583-1607. doi: 10.1007/s00415-016-8384-9. Epub 2017 Jan 4. 13.Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al.Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012
  14. 893–901. 14.Belvisi D, Conte A, Bologna M, et al. Re-emergenttremor in Parkinson's disease, Parkinsonism RelatDisord. 2016
  15. http://dx.doi.org/10.1016/j.parkreldis